Showing 301-310 of 21392 results for "".
- Delayed Puberty and Type 2 Diabetes: Investigating the Long-term Metabolic Impacthttps://reachmd.com/news/delayed-puberty-and-type-2-diabetes-investigating-the-long-term-metabolic-impact/2474595/Extensive research in Israel confirms that delayed puberty in boys is significantly linked to a heightened risk of developing type 2 diabetes in early adulthood—even when adjusting for factors like body weight and socio-economic status.
- Innovative Approaches to Safeguarding Beta Cells in Type 2 Diabeteshttps://reachmd.com/news/innovative-approaches-to-safeguarding-beta-cells-in-type-2-diabetes/2471823/Recent research from the Icahn School of Medicine at Mount Sinai identifies a novel approach to preserving beta cells, offering new hope in the management of type 2 diabetes by countering the detrimental effects of glucolipotoxicity. The breakth
- The Impact of Yo-Yo Dieting on Kidney Health in Type 1 Diabetes Patientshttps://reachmd.com/news/the-impact-of-yo-yo-dieting-on-kidney-health-in-type-1-diabetes-patients/2471159/What's New New evidence links yo-yo dieting to an increased risk of kidney disease in patients with Type 1 diabetes, highlighting the importance of weight stability. Significance The findings underscore the need for healthcare professionals to guide
- Enhancing Glycemic Control: Momordica charantia as an Adjunctive Therapy in Type 2 Diabeteshttps://reachmd.com/news/enhancing-glycemic-control-momordica-charantia-as-an-adjunctive-therapy-in-type-2-diabetes/2485369/In a real-world cohort of adults with type 2 diabetes inadequately controlled on metformin, adding a standardized Momordica charantia extract to metformi
- GLP-1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabeteshttps://reachmd.com/news/glp-1-receptor-agonist-therapy-and-cardiorenal-outcomes-in-type-1-diabetes/2487734/Key Takeaways GLP-1-based therapy was associated with lower risks of all-cause mortality, heart failure, adapted MACE, and all-cause hospitalization in matched adults with type 1 diabetes. No significant differences were observed for myocardial infarction, i
- Navigating the Dual Burden of Type 2 Diabetes: Financial Strain and Digital Solutionshttps://reachmd.com/news/navigating-the-dual-burden-of-type-2-diabetes-financial-strain-and-digital-solutions/2475908/Patients with type 2 diabetes confront a dual burden: the direct health consequences of abnormal blood glucose levels, such as hyperglycemia or hypoglycemia, and the substantial financial strain imposed by high drug and treatment costs. The financial impact of type 2 diabetes is evid
- Early-Onset Type 2 Diabetes Rises in Englandhttps://reachmd.com/news/early-onset-type-2-diabetes-england/2488455/Key Takeaways In England, type 2 diabetes diagnosis rates were reported as rising in adults younger than 40 while falling in older adults from 2011–2024. Women younger than 40 were described as driving the rise, with particularly noticeable increases in white, Asian,
- Study Shows Reciprocal Relationship Between Asthma and Type 2 Diabeteshttps://reachmd.com/news/study-shows-reciprocal-relationship-between-asthma-and-type-2-diabetes/2468138/Individuals with type 2 diabetes (T2D) are more likely to develop asthma – and vice versa, according to an analysis of data on 17 million people being presented at the annual meeting of the European Association for the Study of Diabetes (EA
- Enhancing Type 2 Diabetes Prediction Through Blood Metabolite Signatureshttps://reachmd.com/news/enhancing-type-2-diabetes-prediction-through-blood-metabolite-signatures/2485322/A pooled multi-cohort analysis identified a blood metabolite signature that improves type 2 diabetes prediction beyond traditional clinical ri
- Harnessing Wearable Technology: Enhancing Exercise Adherence in Type 2 Diabeteshttps://reachmd.com/news/harnessing-wearable-technology-enhancing-exercise-adherence-in-type-2-diabetes/2475166/Although low motivation often undermines exercise programs in type 2 diabetes, recent research shows that exercise adherence can improve significantly with